Smartphone medication adherence apps: potential benefits to patients and providers
- PMID: 23571625
- PMCID: PMC3919626
- DOI: 10.1331/JAPhA.2013.12202
Smartphone medication adherence apps: potential benefits to patients and providers
Abstract
Objectives: To provide an overview of medication adherence, discuss the potential for smartphone medication adherence applications (adherence apps) to improve medication nonadherence, evaluate features of adherence apps across operating systems (OSs), and identify future opportunities and barriers facing adherence apps.
Practice description: Medication nonadherence is a common, complex, and costly problem that contributes to poor treatment outcomes and consumes health care resources. Nonadherence is difficult to measure precisely, and interventions to mitigate it have been largely unsuccessful.
Practice innovation: Using smartphone adherence apps represents a novel approach to improving adherence. This readily available technology offers many features that can be designed to help patients and health care providers improve medication-taking behavior.
Main outcome measures: Currently available apps were identified from the three main smartphone OSs (Apple, Android, and Blackberry). In addition, desirable features for adherence apps were identified and ranked by perceived importance to user desirability using a three-point rating system: 1, modest; 2, moderate; or 3, high. The 10 highest-rated apps were installed and subjected to user testing to assess app attributes using a standard medication regimen. RESULTS 160 adherence apps were identified and ranked. These apps were most prevalent for the Android OS. Adherence apps with advanced functionality were more prevalent on the Apple iPhone OS. Among all apps, MyMedSchedule, MyMeds, and RxmindMe rated the highest because of their basic medication reminder features coupled with their enhanced levels of functionality.
Conclusion: Despite being untested, medication apps represent a possible strategy that pharmacists can recommend to nonadherent patients and incorporate into their practice.
Conflict of interest statement
Figures
Comment in
-
Smartphone medication adherence apps: potential benefits to patients and providers: response to Dayer et al.J Am Pharm Assoc (2003). 2013 Jul-Aug;53(4):344-5. doi: 10.1331/JAPhA.2013.13102. J Am Pharm Assoc (2003). 2013. PMID: 23892800 No abstract available.
-
Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst.J Am Pharm Assoc (2003). 2013 Jul-Aug;53(4):345. doi: 10.1331/JAPhA.2013.13121. J Am Pharm Assoc (2003). 2013. PMID: 23892801 No abstract available.
References
-
- Cramer JA, Roy A, Burell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47. - PubMed
-
- Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009;59(1):56–66. - PubMed
-
- Waterhouse DM, Calzone KA, Mele C, Brenner DE. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol. 1993;11(6):1189–1197. - PubMed
-
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. - PubMed
-
- Iihara N, Tsukamoto T, Morita S, et al. Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication. J Clin Pharm Ther. 2004;29(5):417–424. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
